Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02086552 · OUTCOME

Proportion of Patients Who Achieve MRD Negative Status

Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma · Source last updated 2021-12-03

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 3 years

What was measured

Exact binomial 95% confidence intervals for the true MRD negative rate will be calculated.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Exact binomial 95% confidence intervals for the true MRD negative rate will be calculated.
reporting Status
NOT_POSTED
time Frame
Up to 3 years
title
Proportion of Patients Who Achieve MRD Negative Status
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice